Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 16 Apr | 953.00 |
38.35 (4.19%) |
OPEN
922.90 |
HIGH
958.35 |
LOW
910.25 |
| NSE 00:00 | 16 Apr | 953.00 |
37.75 (4.12%) |
OPEN
916.10 |
HIGH
959.00 |
LOW
910.50 |
| OPEN | 922.90 |
| PREVIOUS CLOSE | 914.65 |
| VOLUME | 109979 |
| 52-Week high | |
| 52-Week low | |
| P/E | 18.73 |
| Mkt Cap.(Rs cr) | 55,836 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 646.05 | 2.07 | 155006.77 | 8836.78 | 1918.11 | 12.37 | 52.23 |
| Divi's Lab. | 3823.70 | 1.08 | 101500.12 | 1701.44 | 470.62 | 70.01 | 54.62 |
| Dr Reddy's Labs | 4893.00 | 1.04 | 81370.59 | 4941.90 | 27.90 | 142.98 | 34.22 |
| Cipla | 938.70 | 2.68 | 75701.46 | 5168.69 | 752.51 | 32.98 | 28.46 |
| Aurobindo Pharma | 953.00 | 4.19 | 55836.27 | 6364.91 | 2946.32 | 50.89 | 18.73 |
| Cadila Health. | 527.00 | 4.56 | 53948.99 | 3795.60 | 512.50 | 17.62 | 29.91 |
| Biocon | 412.80 | 2.05 | 49536.00 | 1851.00 | 186.60 | 2.46 | 167.80 |
| Lupin | 1055.85 | 0.58 | 47903.91 | 4017.36 | 441.35 | 25.74 | 41.02 |
| Torrent Pharma. | 2619.15 | 2.06 | 44321.26 | 1995.00 | 297.00 | 60.69 | 43.16 |
| Gland Pharma | 2629.10 | 5.87 | 43012.08 | 859.42 | 204.11 | 56.93 | 46.18 |
| Piramal Enterp. | 1719.50 | 0.26 | 38783.32 | 3168.61 | 799.39 | 0.00 | - |
| Alkem Lab | 2790.45 | 1.57 | 33359.83 | 2318.05 | 463.85 | 133.28 | 20.94 |
| Abbott India | 14962.95 | 0.14 | 31796.27 | 1095.37 | 177.14 | 305.50 | 48.98 |
| Ipca Labs. | 2143.20 | 1.97 | 27186.49 | 1409.83 | 267.56 | 88.06 | 24.34 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
